Rahway, NJ, United States of America

Daniel Zewge


 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • West Orange, NJ (US) (2016)
  • Rahway, NJ (US) (2018 - 2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Daniel Zewge

Introduction

Daniel Zewge is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of RNA interference through his innovative patents. With a total of 4 patents, Zewge's work has advanced the understanding and application of nucleic acid technologies.

Latest Patents

Zewge's latest patents include groundbreaking inventions in the realm of short interfering nucleic acid (siNA) molecules. One of his notable inventions relates to RNAi molecules that incorporate a 2' internucleoside linkage connecting specific nucleotides. This invention focuses on single- and double-stranded siNA molecules capable of mediating RNA interference, utilizing 5' modified nucleotides. Another significant patent involves a process for introducing multiple 2'-modifications into RNA, utilizing amidation reactions and azide-alkyne cycloaddition click chemistry. These advancements highlight Zewge's commitment to enhancing RNA technologies.

Career Highlights

Daniel Zewge is currently employed at Sirna Therapeutics, Inc., where he continues to innovate in the field of RNA research. His work has been instrumental in developing new methodologies that improve the efficacy of RNA-based therapies. Zewge's expertise and dedication to his field have positioned him as a key figure in the biotechnology sector.

Collaborations

Throughout his career, Zewge has collaborated with talented individuals such as Wonsuk Chang and Erin N Guidry. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of research in RNA technologies.

Conclusion

Daniel Zewge's contributions to the field of RNA interference and nucleic acid technologies are noteworthy. His innovative patents and ongoing work at Sirna Therapeutics, Inc. demonstrate his commitment to advancing scientific knowledge and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…